Alle Insider-Transaktionen auf den wichtigsten Aktienmärkten
| Abonnieren, um auf vollständige Daten zuzugreifen | ||||||
|---|---|---|---|---|---|---|
| Unternehmen | Geschäftsfeld | Marktkapitalisierung ($) | # Insidern mit Nettokäufen | Nettowert gekauft ($) | % des Streubesitzes gekauft | % der von Insidern gehaltenen Aktien |
|
|
Pharmaceuticals & Medical Research | Mid (2.5bn) | -1–5 | -$100K–$1M | -0–15% | 15–50% |
|
|
Healthcare Services | Mid (2.3bn) | -1–5 | -$10M–$100M | -0–15% | 0–15% |
|
|
Healthcare Services | Small (1.7bn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Small (1.6bn) | 0 | Keine Aktivität | — | 0–15% |
| Healthcare Services | Small (1.6bn) | 0 | Keine Aktivität | — | 0–15% | |
| Healthcare Services | Small (770.7mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Small (659.0mn) | -1–5 | -$100K–$1M | -0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Small (445.8mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Small (340.9mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Healthcare Services | Small (313.5mn) | 0 | -< $100K | -0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Small (312.6mn) | 0 | -< $100K | -0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Small (301.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Small (294.7mn) | 0 | Keine Aktivität | — | 15–50% |
| Pharmaceuticals & Medical Research | Small (294.6mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Small (266.7mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Small (263.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Small (254.6mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Small (250.1mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Micro (243.3mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Micro (225.6mn) | 6–10 | $1M–$10M | 0–15% | 15–50% |
| Healthcare Services | Micro (220.5mn) | 0 | Keine Aktivität | — | — | |
|
|
Pharmaceuticals & Medical Research | Micro (198.1mn) | 0 | Keine Aktivität | — | — |
|
|
Pharmaceuticals & Medical Research | Micro (182.5mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Micro (181.1mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Micro (164.4mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Healthcare Services | Micro (162.4mn) | 0 | Keine Aktivität | — | 15–50% |
| Pharmaceuticals & Medical Research | Micro (148.8mn) | 0 | Keine Aktivität | — | 0–15% | |
|
|
Healthcare Services | Micro (130.9mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Micro (112.1mn) | -1–5 | -$100K–$1M | -0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Micro (106.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Micro (104.2mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Micro (99.6mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Micro (97.9mn) | 1–5 | $100K–$1M | 0–15% | 0–15% |
| Pharmaceuticals & Medical Research | Micro (97.8mn) | -1–5 | -< $100K | -0–15% | 15–50% | |
| Pharmaceuticals & Medical Research | Micro (95.5mn) | 0 | Keine Aktivität | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Micro (95.4mn) | 1–5 | < $100K | 0–15% | 0–15% |
| Pharmaceuticals & Medical Research | Micro (93.9mn) | 0 | Keine Aktivität | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Micro (90.2mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Micro (76.1mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Micro (71.4mn) | 0 | Keine Aktivität | — | 15–50% |
| Healthcare Services | Micro (62.1mn) | 0 | Keine Aktivität | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Micro (54.5mn) | 0 | Keine Aktivität | — | 50%+ |
| Pharmaceuticals & Medical Research | Micro (52.2mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (49.6mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Healthcare Services | Nano (48.4mn) | 0 | Keine Aktivität | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (47.7mn) | 0 | -< $100K | -0–15% | 50%+ | |
|
|
Pharmaceuticals & Medical Research | Nano (47.6mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (45.4mn) | -1–5 | -< $100K | -0–15% | 0–15% |
| Healthcare Services | Nano (44.1mn) | 6–10 | $100K–$1M | 0–15% | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (41.3mn) | 1–5 | < $100K | 0–15% | 15–50% |
| Healthcare Services | Nano (37.8mn) | 1–5 | < $100K | 0–15% | 0–15% | |
| Healthcare Services | Nano (37.6mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (37.2mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (35.6mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (34.6mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (32.9mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (31.1mn) | -1–5 | -< $100K | -0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (30.1mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Healthcare Services | Nano (28.9mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (28.5mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (26.4mn) | 1–5 | < $100K | 0–15% | 15–50% |
| Pharmaceuticals & Medical Research | Nano (25.9mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Healthcare Services | Nano (25.8mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (25.3mn) | 1–5 | $100K–$1M | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (25.0mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (24.4mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (23.8mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (22.8mn) | -1–5 | -< $100K | -0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (21.4mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (21.1mn) | 0 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (19.7mn) | 0 | Keine Aktivität | — | 15–50% |
| Healthcare Services | Nano (16.9mn) | 0 | Keine Aktivität | — | 15–50% | |
| Healthcare Services | Nano (15.7mn) | 0 | Keine Aktivität | — | 0–15% | |
|
|
Healthcare Services | Nano (14.1mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (14.0mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (13.9mn) | 0 | Keine Aktivität | — | — |
|
|
Healthcare Services | Nano (12.2mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (12.2mn) | 0 | Keine Aktivität | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (12.2mn) | 0 | Keine Aktivität | — | 0–15% | |
|
|
Healthcare Services | Nano (11.7mn) | 0 | Keine Aktivität | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (11.7mn) | 1–5 | < $100K | 0–15% | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (11.6mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (11.4mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | -$100K–$1M | -0–15% | 15–50% |
| Pharmaceuticals & Medical Research | Nano (11.0mn) | 0 | Keine Aktivität | — | 15–50% | |
| Pharmaceuticals & Medical Research | Nano (10.5mn) | -1–5 | -$1M–$10M | -15–50% | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (10.3mn) | 0 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (7.0mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (6.6mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (6.5mn) | 0 | Keine Aktivität | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (6.3mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (4.9mn) | 0 | Keine Aktivität | — | — |
|
|
Healthcare Services | Nano (4.4mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (4.2mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (4.2mn) | 0 | Keine Aktivität | — | 15–50% |